Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Summary of patient demographics

From: Dietary ω-6 polyunsaturated fatty acid arachidonic acid increases inflammation, but inhibits ECM protein expression in COPD

All patients n = 82
  Non-COPD (n = 50) COPD (n = 32)
Characteristics Resection for thoracic malignancy
(n = 17)
End stage lung disease other than COPD
(n = 33)
 
Pathology 1. IPF (n = 17) (51.5%)
2. Pulmonary hypertension (n = 4) (12.1%)
3. Eisenmenger’s syndrome (n = 2) (6.1%)
4. BOS (n = 2) (6.1%)
5. Bronchiectasis (n = 2) (6.1%)
6. Other (n = 6) (18.2%)
1. Emphysema or COPD (n = 28) (87.5%)
2. α1-antitrypsin deficiency (n = 4) (12.5%)
Sex (n) Female/Male 13/4 11/22 13/19
Mean age (years) (SD) 61.0 (9.7) 55.5 (13.4) 59.1 (8.7)
Mean BMI (kg/m2)(SD) 25.0 (5.2) 25.4 (5.3) 23.8 (4.0)
Smokers/non-smokers/unk
(% smokers)
12/2/3
(70.5%)
15/9/9
(45%)
28/2/2
(87.5%)
  1. COPD Chronic obstructive pulmonary disease, IPF Idiopathic pulmonary fibrosis, BOS Bronchiolitis obliterans syndrome, unk data Unknown, SD Standard deviation, BMI Body mass index